Medicine & Life Sciences

1. Mucopolysaccharidosis I 100%
2. GM1 Gangliosidosis 96%
3. Gangliosidoses 73%
4. Gaucher Disease 65%
5. Iduronidase 58%
6. eliglustat 42%
7. Enzyme Replacement Therapy 39%
8. Glucosylceramidase 34%
9. chitotriosidase 34%
10. Mucopolysaccharidosis II 32%
11. Galactosidases 32%
12. GM2 Gangliosidosis 31%
13. Caregivers 30%
14. sapropterin 29%
15. Musculoskeletal Diseases 28%
16. TimeLine 27%
17. Phenylketonurias 27%
18. Adalimumab 26%
19. Gene Editing 26%
20. Symptom Assessment 24%
21. Pharmacogenetics 24%
22. Blood-Brain Barrier 24%
23. Standard of Care 23%
24. Therapeutics 22%
25. Enzymes 22%
26. Gyrus Cinguli 22%
27. Cardiovascular System 20%
28. Placebos 19%
29. Cell Transplantation 19%
30. Phenotype 19%
31. Glutamic Acid 18%
32. Biomarkers 17%
33. Safety 17%
34. Pharmacokinetics 17%
35. Parents 16%
36. Putamen 15%
37. Oxidative Stress 15%
38. Monoclonal Antibodies 15%
39. Genotype 15%
40. Pain 14%
41. Alleles 14%
42. Gangliosides 14%
43. White Matter 12%
44. Mutation 12%
45. Walking 12%
46. Magnetic Resonance Spectroscopy 11%
47. isospaglumic acid 11%
48. Phenylalanine Hydroxylase 11%
49. Longevity 11%
50. Clinical Trials 11%